Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
fda
biotech
boston blog main
boston top stories
amgen
detroit blog main
detroit top stories
national
national top stories
new york blog main
new york top stories
paul matteis
san francisco blog main
san francisco top stories
abaloparatide
abbvie
acorda therapeutics
acute hepatic porphyrias
akin akinc
alder biopharmaceuticals
alnylam pharmaceuticals
aminolevulinic acid
ampyra
apokyn
apomorphine
bempedoic acid
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
cholesterol
chronic migraine
corticosteroids
dalfampridine
david rind
detroit
drugs
What
drug
5
×
nod
5
×
fda
approval
amgen
approved
developed
gets
medicine
medicines
new
second
wins
acorda
ago
alnylam
amgen’s
candidates
carries
cholesterol
class
combo
cope
disease
episodes
esperion
esperion’s
europe
european
friday
head
heart
help
indicated
interference
late
levels
looms
lowering
marketing
Language
unset
Current search:
drug
×
nod
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines